Contractor audit failings jump into MHRA top 10 deficiencies
Failure to properly audit suppliers and contractors jumped into the top 10 MHRA inspection findings last fiscal year.
Failure to properly audit suppliers and contractors jumped into the top 10 MHRA inspection findings last fiscal year.
West Pharmaceutical Services expects significant growth from biosimilars as manufacturers use novel delivery devices as a “key differentiator”.
EXCLUSIVE
More than a third of patient recruitment will be done in emerging markets in the future, predicts Chiltern CEO Glenn Kerkhof.
The US FDA has issued a warning about Hospira’s Carpuject prefilled cartridges after batches were found containing more than twice the amount of recommended dosage.
Albemarle is increasing its prices for the active pharmaceutical ingredient (API) ibuprofen by 15 per cent.
The EMA has cleared the Roche oncology blockbuster MabThera after concluding contamination of API bioreactors poses little threat.